Review



anti pol ii f 12  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Santa Cruz Biotechnology anti pol ii f 12
    Anti Pol Ii F 12, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1666 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+pol+ii+f+12/Pol+II+Antibody/10__1158_slash_1535___7163__mct___25___0271-81-29-33
    Average 97 stars, based on 1666 article reviews
    anti pol ii f 12 - by Bioz Stars, 2026-09
    97/100 stars

    Images

    Related Articles

    Incubation:

    Article Title: A Novel Dual-Payload ADC Platform Integrating Exatecan and Triptolide to Enhance Antitumor Efficacy and Overcome Resistance
    Article Snippet: Proteins were transferred to polyvinylidene dif luoride (PVDF) membranes (Merck Millipore, IPVH00010) at 4°C with a current of 255 mA for 1200 minutes. .. PVDF membranes were blocked in skim milk for 2 hours and then incubated overnight at 4°C with the following antibodies : anti-HSP70 (1:500, Beyotime, AF0189), anti-TOP1 (1:1000, BD, 556597), anti-Pol II (F-12) (1:500, Santa Cruz Biotechnology, sc-55492), and anti-α-tubulin (1:2000, Immunoway, YT4777). ..



    Similar Products

    97
    Santa Cruz Biotechnology anti pol ii f 12
    Anti Pol Ii F 12, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+pol+ii+f+12/Pol+II+Antibody/10__1158_slash_1535___7163__mct___25___0271-81-29-33
    Average 97 stars, based on 1 article reviews
    anti pol ii f 12 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology anti rna pol ii f 12
    Argonaute 1 (Ago1) interacts with initiating and elongating RNAPII in cells . A, Ago1 is recruited to the chromatin fraction in an RNA-dependent manner. Cytoplasmic, nucleoplasmic, and chromatin-associated protein extracts were prepared from HeLa cells either untreated (NT) or treated with actinomycin D (ActD) at a 10 μg/ml final concentration to block transcription. Untreated cells were further either mock-treated or incubated with RNase A. Cytoplasmic, nucleoplasmic, and chromatin fractions were loaded on SDS-PAGE, and Ago1 and RNAPII (RPB1) were visualized using indicated antibodies. For each condition, three lanes are shown: NT (no ActD, no RNase), RNase A (no ActD, treated with RNase A), and ActD (ActD treated, no RNase A). GAPDH, EXOSC10, and histone H3 (H3 Tot) serve as markers for the cytoplasmic, nucleoplasmic, and chromatin fractions, respectively (n = 3 independent experiment, a representative image is shown). B, Ago1 interacts with endogenous RNAPII in nuclei of HeLa cells. Endogenous RNAPII was immunoprecipitated from nuclear extracts using an antibody targeting RPB1, the largest subunit of RNAPII. shAgo1-mediated Ago1 downregulation (6 days post shRNA transduction) served as a negative control for the interaction. GAPDH was used as additional negative and fractionation control. A representative image from n = 3 independent experiments is shown. C, reverse coimmunoprecipitation experiments were performed in HEK-293T cells either overexpressing, or not, Ago1-FLAG-HA, using an anti-FLAG antibody, in the absence (−) or presence (+) of RNase treatment. Ser5-phosphorylated (RNAPII-S5P) and Ser2-phosphorylated (RNAPII-S2P) forms of RNAPII serve as markers of the initiating and elongating transcriptional complexes, respectively. A representative result from n = 3 independent experiments is shown. HEK-293T, human embryonic kidney 293T cell line; RNAPII, RNA polymerase II.
    Anti Rna Pol Ii F 12, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+pol+ii+f+12/Pol+II+Antibody/pmc12466236-218-59-64
    Average 97 stars, based on 1 article reviews
    anti rna pol ii f 12 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology mouse monoclonal f 12 sc 55492
    Argonaute 1 (Ago1) interacts with initiating and elongating RNAPII in cells . A, Ago1 is recruited to the chromatin fraction in an RNA-dependent manner. Cytoplasmic, nucleoplasmic, and chromatin-associated protein extracts were prepared from HeLa cells either untreated (NT) or treated with actinomycin D (ActD) at a 10 μg/ml final concentration to block transcription. Untreated cells were further either mock-treated or incubated with RNase A. Cytoplasmic, nucleoplasmic, and chromatin fractions were loaded on SDS-PAGE, and Ago1 and RNAPII (RPB1) were visualized using indicated antibodies. For each condition, three lanes are shown: NT (no ActD, no RNase), RNase A (no ActD, treated with RNase A), and ActD (ActD treated, no RNase A). GAPDH, EXOSC10, and histone H3 (H3 Tot) serve as markers for the cytoplasmic, nucleoplasmic, and chromatin fractions, respectively (n = 3 independent experiment, a representative image is shown). B, Ago1 interacts with endogenous RNAPII in nuclei of HeLa cells. Endogenous RNAPII was immunoprecipitated from nuclear extracts using an antibody targeting RPB1, the largest subunit of RNAPII. shAgo1-mediated Ago1 downregulation (6 days post shRNA transduction) served as a negative control for the interaction. GAPDH was used as additional negative and fractionation control. A representative image from n = 3 independent experiments is shown. C, reverse coimmunoprecipitation experiments were performed in HEK-293T cells either overexpressing, or not, Ago1-FLAG-HA, using an anti-FLAG antibody, in the absence (−) or presence (+) of RNase treatment. Ser5-phosphorylated (RNAPII-S5P) and Ser2-phosphorylated (RNAPII-S2P) forms of RNAPII serve as markers of the initiating and elongating transcriptional complexes, respectively. A representative result from n = 3 independent experiments is shown. HEK-293T, human embryonic kidney 293T cell line; RNAPII, RNA polymerase II.
    Mouse Monoclonal F 12 Sc 55492, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+pol+ii+f+12/Pol+II+Antibody/pm38956169-1009-111-115
    Average 97 stars, based on 1 article reviews
    mouse monoclonal f 12 sc 55492 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology f 12
    Argonaute 1 (Ago1) interacts with initiating and elongating RNAPII in cells . A, Ago1 is recruited to the chromatin fraction in an RNA-dependent manner. Cytoplasmic, nucleoplasmic, and chromatin-associated protein extracts were prepared from HeLa cells either untreated (NT) or treated with actinomycin D (ActD) at a 10 μg/ml final concentration to block transcription. Untreated cells were further either mock-treated or incubated with RNase A. Cytoplasmic, nucleoplasmic, and chromatin fractions were loaded on SDS-PAGE, and Ago1 and RNAPII (RPB1) were visualized using indicated antibodies. For each condition, three lanes are shown: NT (no ActD, no RNase), RNase A (no ActD, treated with RNase A), and ActD (ActD treated, no RNase A). GAPDH, EXOSC10, and histone H3 (H3 Tot) serve as markers for the cytoplasmic, nucleoplasmic, and chromatin fractions, respectively (n = 3 independent experiment, a representative image is shown). B, Ago1 interacts with endogenous RNAPII in nuclei of HeLa cells. Endogenous RNAPII was immunoprecipitated from nuclear extracts using an antibody targeting RPB1, the largest subunit of RNAPII. shAgo1-mediated Ago1 downregulation (6 days post shRNA transduction) served as a negative control for the interaction. GAPDH was used as additional negative and fractionation control. A representative image from n = 3 independent experiments is shown. C, reverse coimmunoprecipitation experiments were performed in HEK-293T cells either overexpressing, or not, Ago1-FLAG-HA, using an anti-FLAG antibody, in the absence (−) or presence (+) of RNase treatment. Ser5-phosphorylated (RNAPII-S5P) and Ser2-phosphorylated (RNAPII-S2P) forms of RNAPII serve as markers of the initiating and elongating transcriptional complexes, respectively. A representative result from n = 3 independent experiments is shown. HEK-293T, human embryonic kidney 293T cell line; RNAPII, RNA polymerase II.
    F 12, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+pol+ii+f+12/Pol+II+Antibody/pmc11126984-292-9-10
    Average 97 stars, based on 1 article reviews
    f 12 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology f 12 santa cruz sc 55492 mouse anti spt5
    Argonaute 1 (Ago1) interacts with initiating and elongating RNAPII in cells . A, Ago1 is recruited to the chromatin fraction in an RNA-dependent manner. Cytoplasmic, nucleoplasmic, and chromatin-associated protein extracts were prepared from HeLa cells either untreated (NT) or treated with actinomycin D (ActD) at a 10 μg/ml final concentration to block transcription. Untreated cells were further either mock-treated or incubated with RNase A. Cytoplasmic, nucleoplasmic, and chromatin fractions were loaded on SDS-PAGE, and Ago1 and RNAPII (RPB1) were visualized using indicated antibodies. For each condition, three lanes are shown: NT (no ActD, no RNase), RNase A (no ActD, treated with RNase A), and ActD (ActD treated, no RNase A). GAPDH, EXOSC10, and histone H3 (H3 Tot) serve as markers for the cytoplasmic, nucleoplasmic, and chromatin fractions, respectively (n = 3 independent experiment, a representative image is shown). B, Ago1 interacts with endogenous RNAPII in nuclei of HeLa cells. Endogenous RNAPII was immunoprecipitated from nuclear extracts using an antibody targeting RPB1, the largest subunit of RNAPII. shAgo1-mediated Ago1 downregulation (6 days post shRNA transduction) served as a negative control for the interaction. GAPDH was used as additional negative and fractionation control. A representative image from n = 3 independent experiments is shown. C, reverse coimmunoprecipitation experiments were performed in HEK-293T cells either overexpressing, or not, Ago1-FLAG-HA, using an anti-FLAG antibody, in the absence (−) or presence (+) of RNase treatment. Ser5-phosphorylated (RNAPII-S5P) and Ser2-phosphorylated (RNAPII-S2P) forms of RNAPII serve as markers of the initiating and elongating transcriptional complexes, respectively. A representative result from n = 3 independent experiments is shown. HEK-293T, human embryonic kidney 293T cell line; RNAPII, RNA polymerase II.
    F 12 Santa Cruz Sc 55492 Mouse Anti Spt5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+pol+ii+f+12/Pol+II+Antibody/pmc10689479__41467_2023_43724_MOESM9_ESM-120-16-17
    Average 97 stars, based on 1 article reviews
    f 12 santa cruz sc 55492 mouse anti spt5 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology anti pol ii antibody f 12
    Argonaute 1 (Ago1) interacts with initiating and elongating RNAPII in cells . A, Ago1 is recruited to the chromatin fraction in an RNA-dependent manner. Cytoplasmic, nucleoplasmic, and chromatin-associated protein extracts were prepared from HeLa cells either untreated (NT) or treated with actinomycin D (ActD) at a 10 μg/ml final concentration to block transcription. Untreated cells were further either mock-treated or incubated with RNase A. Cytoplasmic, nucleoplasmic, and chromatin fractions were loaded on SDS-PAGE, and Ago1 and RNAPII (RPB1) were visualized using indicated antibodies. For each condition, three lanes are shown: NT (no ActD, no RNase), RNase A (no ActD, treated with RNase A), and ActD (ActD treated, no RNase A). GAPDH, EXOSC10, and histone H3 (H3 Tot) serve as markers for the cytoplasmic, nucleoplasmic, and chromatin fractions, respectively (n = 3 independent experiment, a representative image is shown). B, Ago1 interacts with endogenous RNAPII in nuclei of HeLa cells. Endogenous RNAPII was immunoprecipitated from nuclear extracts using an antibody targeting RPB1, the largest subunit of RNAPII. shAgo1-mediated Ago1 downregulation (6 days post shRNA transduction) served as a negative control for the interaction. GAPDH was used as additional negative and fractionation control. A representative image from n = 3 independent experiments is shown. C, reverse coimmunoprecipitation experiments were performed in HEK-293T cells either overexpressing, or not, Ago1-FLAG-HA, using an anti-FLAG antibody, in the absence (−) or presence (+) of RNase treatment. Ser5-phosphorylated (RNAPII-S5P) and Ser2-phosphorylated (RNAPII-S2P) forms of RNAPII serve as markers of the initiating and elongating transcriptional complexes, respectively. A representative result from n = 3 independent experiments is shown. HEK-293T, human embryonic kidney 293T cell line; RNAPII, RNA polymerase II.
    Anti Pol Ii Antibody F 12, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+pol+ii+f+12/Pol+II+Antibody/pm36645269-231-0-11
    Average 97 stars, based on 1 article reviews
    anti pol ii antibody f 12 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    97
    Santa Cruz Biotechnology f 12 santa cruz biotechnology cat
    Argonaute 1 (Ago1) interacts with initiating and elongating RNAPII in cells . A, Ago1 is recruited to the chromatin fraction in an RNA-dependent manner. Cytoplasmic, nucleoplasmic, and chromatin-associated protein extracts were prepared from HeLa cells either untreated (NT) or treated with actinomycin D (ActD) at a 10 μg/ml final concentration to block transcription. Untreated cells were further either mock-treated or incubated with RNase A. Cytoplasmic, nucleoplasmic, and chromatin fractions were loaded on SDS-PAGE, and Ago1 and RNAPII (RPB1) were visualized using indicated antibodies. For each condition, three lanes are shown: NT (no ActD, no RNase), RNase A (no ActD, treated with RNase A), and ActD (ActD treated, no RNase A). GAPDH, EXOSC10, and histone H3 (H3 Tot) serve as markers for the cytoplasmic, nucleoplasmic, and chromatin fractions, respectively (n = 3 independent experiment, a representative image is shown). B, Ago1 interacts with endogenous RNAPII in nuclei of HeLa cells. Endogenous RNAPII was immunoprecipitated from nuclear extracts using an antibody targeting RPB1, the largest subunit of RNAPII. shAgo1-mediated Ago1 downregulation (6 days post shRNA transduction) served as a negative control for the interaction. GAPDH was used as additional negative and fractionation control. A representative image from n = 3 independent experiments is shown. C, reverse coimmunoprecipitation experiments were performed in HEK-293T cells either overexpressing, or not, Ago1-FLAG-HA, using an anti-FLAG antibody, in the absence (−) or presence (+) of RNase treatment. Ser5-phosphorylated (RNAPII-S5P) and Ser2-phosphorylated (RNAPII-S2P) forms of RNAPII serve as markers of the initiating and elongating transcriptional complexes, respectively. A representative result from n = 3 independent experiments is shown. HEK-293T, human embryonic kidney 293T cell line; RNAPII, RNA polymerase II.
    F 12 Santa Cruz Biotechnology Cat, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+pol+ii+f+12/Pol+II+Antibody/pm36516773-255-67-68
    Average 97 stars, based on 1 article reviews
    f 12 santa cruz biotechnology cat - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    Image Search Results


    Argonaute 1 (Ago1) interacts with initiating and elongating RNAPII in cells . A, Ago1 is recruited to the chromatin fraction in an RNA-dependent manner. Cytoplasmic, nucleoplasmic, and chromatin-associated protein extracts were prepared from HeLa cells either untreated (NT) or treated with actinomycin D (ActD) at a 10 μg/ml final concentration to block transcription. Untreated cells were further either mock-treated or incubated with RNase A. Cytoplasmic, nucleoplasmic, and chromatin fractions were loaded on SDS-PAGE, and Ago1 and RNAPII (RPB1) were visualized using indicated antibodies. For each condition, three lanes are shown: NT (no ActD, no RNase), RNase A (no ActD, treated with RNase A), and ActD (ActD treated, no RNase A). GAPDH, EXOSC10, and histone H3 (H3 Tot) serve as markers for the cytoplasmic, nucleoplasmic, and chromatin fractions, respectively (n = 3 independent experiment, a representative image is shown). B, Ago1 interacts with endogenous RNAPII in nuclei of HeLa cells. Endogenous RNAPII was immunoprecipitated from nuclear extracts using an antibody targeting RPB1, the largest subunit of RNAPII. shAgo1-mediated Ago1 downregulation (6 days post shRNA transduction) served as a negative control for the interaction. GAPDH was used as additional negative and fractionation control. A representative image from n = 3 independent experiments is shown. C, reverse coimmunoprecipitation experiments were performed in HEK-293T cells either overexpressing, or not, Ago1-FLAG-HA, using an anti-FLAG antibody, in the absence (−) or presence (+) of RNase treatment. Ser5-phosphorylated (RNAPII-S5P) and Ser2-phosphorylated (RNAPII-S2P) forms of RNAPII serve as markers of the initiating and elongating transcriptional complexes, respectively. A representative result from n = 3 independent experiments is shown. HEK-293T, human embryonic kidney 293T cell line; RNAPII, RNA polymerase II.

    Journal: The Journal of Biological Chemistry

    Article Title: Argonaute 1 contributes to the transcriptional silencing of HIV-1

    doi: 10.1016/j.jbc.2025.110612

    Figure Lengend Snippet: Argonaute 1 (Ago1) interacts with initiating and elongating RNAPII in cells . A, Ago1 is recruited to the chromatin fraction in an RNA-dependent manner. Cytoplasmic, nucleoplasmic, and chromatin-associated protein extracts were prepared from HeLa cells either untreated (NT) or treated with actinomycin D (ActD) at a 10 μg/ml final concentration to block transcription. Untreated cells were further either mock-treated or incubated with RNase A. Cytoplasmic, nucleoplasmic, and chromatin fractions were loaded on SDS-PAGE, and Ago1 and RNAPII (RPB1) were visualized using indicated antibodies. For each condition, three lanes are shown: NT (no ActD, no RNase), RNase A (no ActD, treated with RNase A), and ActD (ActD treated, no RNase A). GAPDH, EXOSC10, and histone H3 (H3 Tot) serve as markers for the cytoplasmic, nucleoplasmic, and chromatin fractions, respectively (n = 3 independent experiment, a representative image is shown). B, Ago1 interacts with endogenous RNAPII in nuclei of HeLa cells. Endogenous RNAPII was immunoprecipitated from nuclear extracts using an antibody targeting RPB1, the largest subunit of RNAPII. shAgo1-mediated Ago1 downregulation (6 days post shRNA transduction) served as a negative control for the interaction. GAPDH was used as additional negative and fractionation control. A representative image from n = 3 independent experiments is shown. C, reverse coimmunoprecipitation experiments were performed in HEK-293T cells either overexpressing, or not, Ago1-FLAG-HA, using an anti-FLAG antibody, in the absence (−) or presence (+) of RNase treatment. Ser5-phosphorylated (RNAPII-S5P) and Ser2-phosphorylated (RNAPII-S2P) forms of RNAPII serve as markers of the initiating and elongating transcriptional complexes, respectively. A representative result from n = 3 independent experiments is shown. HEK-293T, human embryonic kidney 293T cell line; RNAPII, RNA polymerase II.

    Article Snippet: Membranes were blocked in Tris-buffered saline with 0.1% Tween-20 and 5% milk or 5% bovine serum albumin for 30 min at room temperature, followed by overnight incubation at 4 °C with the specified primary antibodies: anti-Ago1 4B8 (SAB4200084; Sigma), anti-Ago1 D84G10 (5053; Cell Signaling), anti-Ago2 C34C6 (2897; Cell Signaling), anti-Dicer A-2 (sc-136981; Santa Cruz), anti-Drosha D28B1 (3364; Cell Signaling), anti-RNA Pol II F-12 (sc-55492; Santa Cruz), anti-RNA Pol II phospho-Ser2 E1Z3G (13499; Cell Signaling), anti-RNA Pol II phospho-Ser5 (ab5131; Abcam), anti-GAPDH (sc-47724; Santa Cruz), and anti-α-Tubulin (T9026; Sigma–Aldrich).

    Techniques: Concentration Assay, Blocking Assay, Incubation, SDS Page, Immunoprecipitation, shRNA, Transduction, Negative Control, Fractionation, Control

    Model of the role of Argonaute 1 (Ago1) in transcriptional repression of the HIV-1 promoter. Ago1 is recruited to the HIV-1 promoter likely through RNA-dependent interactions, potentially involving LTR-driven nascent transcripts, possibly noncoding RNAs, but independently of miRNAs. Once associated with chromatin and RNA polymerase II (RNAPII), Ago1 may contribute to transcriptional repression either directly or by stabilizing a repressive chromatin environment at the promoter. This repressive function appears specific to Ago1 and does involve neither canonical miRNA pathway components nor the microprocessor or HUSH complexes. While mechanistically distinct from the RITS complex in Saccharomyces pombe , whose closest functional counterpart in human cells is the HUSH complex, this mechanism may reflect an evolutionary echo of RNA-guided transcriptional silencing strategies observed in lower eukaryotes. Ago1 may then serve as a scaffold for chromatin-modifying machineries, facilitating heterochromatinization of the viral promoter and contributing to the HIV-1 transcriptional silencing. RITS, RNA-induced transcriptional silencing.

    Journal: The Journal of Biological Chemistry

    Article Title: Argonaute 1 contributes to the transcriptional silencing of HIV-1

    doi: 10.1016/j.jbc.2025.110612

    Figure Lengend Snippet: Model of the role of Argonaute 1 (Ago1) in transcriptional repression of the HIV-1 promoter. Ago1 is recruited to the HIV-1 promoter likely through RNA-dependent interactions, potentially involving LTR-driven nascent transcripts, possibly noncoding RNAs, but independently of miRNAs. Once associated with chromatin and RNA polymerase II (RNAPII), Ago1 may contribute to transcriptional repression either directly or by stabilizing a repressive chromatin environment at the promoter. This repressive function appears specific to Ago1 and does involve neither canonical miRNA pathway components nor the microprocessor or HUSH complexes. While mechanistically distinct from the RITS complex in Saccharomyces pombe , whose closest functional counterpart in human cells is the HUSH complex, this mechanism may reflect an evolutionary echo of RNA-guided transcriptional silencing strategies observed in lower eukaryotes. Ago1 may then serve as a scaffold for chromatin-modifying machineries, facilitating heterochromatinization of the viral promoter and contributing to the HIV-1 transcriptional silencing. RITS, RNA-induced transcriptional silencing.

    Article Snippet: Membranes were blocked in Tris-buffered saline with 0.1% Tween-20 and 5% milk or 5% bovine serum albumin for 30 min at room temperature, followed by overnight incubation at 4 °C with the specified primary antibodies: anti-Ago1 4B8 (SAB4200084; Sigma), anti-Ago1 D84G10 (5053; Cell Signaling), anti-Ago2 C34C6 (2897; Cell Signaling), anti-Dicer A-2 (sc-136981; Santa Cruz), anti-Drosha D28B1 (3364; Cell Signaling), anti-RNA Pol II F-12 (sc-55492; Santa Cruz), anti-RNA Pol II phospho-Ser2 E1Z3G (13499; Cell Signaling), anti-RNA Pol II phospho-Ser5 (ab5131; Abcam), anti-GAPDH (sc-47724; Santa Cruz), and anti-α-Tubulin (T9026; Sigma–Aldrich).

    Techniques: Functional Assay